Noni — Benefits Deep Dive

Noni is the fruit of Morinda citrifolia, a salt-tolerant tree of the coffee family that Polynesian voyagers carried across the Pacific as a dye plant, a famine food and a targeted remedy. Since the mid-1990s it has been sold worldwide as a bottled juice promoted for pain, immunity, energy, blood sugar, blood pressure, cancer and general wellbeing. Those two histories — the ethnobotanical one and the commercial one — are frequently blended together in marketing copy, and the blend is what makes noni hard to read honestly.

This Benefits section documents every major claim made for noni and labels what actually stands behind it. That is the site's standing policy: a claimed use is written down and graded, never quietly dropped, and where a claim sits next to documented harm the harm is stated in the same breath. For noni the honest summary is uncomfortable in both directions. The famous claims rest overwhelmingly on cell-culture and rodent work. At the same time the dismissive position — "harmless fruit juice, ignore it" — is also wrong, because noni carries two real, documented hazards that most supplement pages never mention.

The two hazards, stated up front. First, several independent European hepatology and gastroenterology groups have published case reports of acute hepatitis in people drinking noni juice, including a 29-year-old man whose liver failed after 1.5 L of noni juice over 3 weeks and who needed an urgent liver transplant. The European Food Safety Authority and its predecessor committee reviewed this material, judged the juice acceptable for the general population at ordinary intakes, and left it on the market while explicitly acknowledging the reports and the possibility of individual (idiosyncratic) susceptibility. Second, noni juice is high in potassium — measured at 56.3 mEq/L, similar to orange and tomato juice — and a published report describes hyperkalaemia in a patient with renal insufficiency. For anyone with chronic kidney disease, or on a potassium-sparing diuretic, an angiotensin-converting enzyme inhibitor (ACE inhibitor) or an angiotensin receptor blocker (ARB), that is not a theoretical concern. The man in the published report was following a low-potassium diet and still developed hyperkalaemia (high blood potassium).

One practical point that undercuts almost every dose discussion. Ripe noni smells of ripe cheese and tastes bitter and ammoniacal, so retail "noni juice" is very often blended with grape, blueberry, apple or other sweet juices, sometimes with added sugar. A bottle labelled noni may be a minority noni by volume. That changes the sugar content, changes the potassium content, and means the "30 ml daily" on the label does not correspond to the amount of noni used in any study you might read about. Checking the actual percentage on the ingredient list is the single most useful thing a reader can do.

Table of Contents

  1. Deep-Dive Articles
  2. How the Evidence Is Labelled
  3. The Claim Map at a Glance
  4. Key Research: Liver Injury and the Case Reports
  5. Key Research: Potassium, Kidneys and Hyperkalaemia
  6. Key Research: Pain, Joints and Inflammation
  7. Key Research: Immune Activity and Antioxidant Chemistry
  8. Key Research: Energy, Quality of Life and Trial Design
  9. Traditional Use, Described Accurately
  10. External Resources
  11. Connections
  12. Featured Videos

Deep-Dive Articles

Four articles, each written to be read on its own. The safety article covers the part of the noni story that the promotional literature omits and the part most likely to change what somebody does.

How the Evidence Is Labelled

Every claim in these four articles carries one of five labels. The labels are doing real work here, because noni's literature contains a great deal of laboratory material presented in marketing as though it were clinical proof.

The Claim Map at a Glance

Noni is marketed for an essentially unbounded list of conditions, which is itself the clearest signal that the list is not evidence-driven — genuinely effective treatments have narrow indications. Here is the map these articles work through:

Key Research: Liver Injury and the Case Reports

This is the best-documented part of the noni literature, and it is documented in mainstream hepatology journals rather than in advocacy publications. The reports come from several independent European centres and describe a broadly consistent picture: a hepatocellular pattern of injury with markedly raised transaminases, jaundice, fatigue and nausea, appearing weeks to a few months into regular consumption and improving after the juice was stopped.

  1. Millonig, Stadlmann and Vogel, European Journal of Gastroenterology & Hepatology, 2005 — "Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia)". The index case in the published literature: a 45-year-old man who had drunk noni juice for 3 weeks; a liver biopsy confirmed herbal toxicity, and his liver tests were back in the normal range 1 month after he stopped. PubMed PMID: 15756098
  2. Stadlbauer and colleagues, World Journal of Gastroenterology, 2005 — "Hepatotoxicity of NONI juice: report of two cases", from Graz, with liver biopsy findings. A 29-year-old man, who had earlier had toxic hepatitis linked to small doses of paracetamol, developed sub-acute liver failure after drinking 1.5 L of noni juice over 3 weeks and needed an urgent liver transplant. A 62-year-old woman with no earlier liver disease developed a self-limited acute hepatitis after 2 L of noni juice over more than 3 months and recovered after stopping. The authors named anthraquinones as the most likely liver-toxic components. PubMed PMID: 16094725
  3. Yüce, Gülberg, Diebold and Gerbes, Digestion, 2006 — "Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg?" The title's question has never been definitively answered. A 24-year-old woman, who had also been treated with interferon beta-1a for multiple sclerosis, had drunk noni juice for 4 weeks and was admitted with fulminant hepatitis and suspected beginning acute liver failure; her liver tests were normal within 1 month of stopping the juice. PubMed PMID: 16837801
  4. Stadlbauer and colleagues, American Journal of Gastroenterology, 2008 — a follow-up case report whose title makes the general point that "herbal" does not mean innocuous, describing a further noni-associated hepatotoxicity case (title: "Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with morinda citrifolia (noni)"). PubMed PMID: 18844633
  5. Kim and colleagues, Journal of Investigative Medicine High Impact Case Reports, 2026 — "A Case Report: Drug-Induced Liver Injury from Prolonged Topical Application of Noni (Morinda citrifolia)". A 60-year-old man developed jaundice, itching all over, dark urine and pale stools, with a cholestatic pattern of liver injury, after using a noni-containing pain-relief cream on his skin for about 8 months (he had stopped it 3 months before the symptoms began). Other causes were ruled out, and his liver tests returned to normal 6 months after he left hospital. The authors write that liver injury from noni used on the skin had not been described before. PubMed PMID: 41805431
  6. The opposing view — West, Jensen and Westendorf, World Journal of Gastroenterology, 2006, "Noni juice is not hepatotoxic" PubMed PMID: 16773722, and West, Su and Jensen, The Journal of Toxicological Sciences, 2009, "Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (noni) fruit", reporting hepatotoxicity and subchronic toxicity testing in animals without liver injury at high doses. In that rat study the no-observed-adverse-effect level for freeze-dried noni fruit puree was greater than 6.86 g/kg body weight (equivalent to approximately 90 ml of noni fruit juice per kg), with no tissue changes and no dose-related changes in blood tests, including liver function tests; the authors write that in the human cases "no causal link could be established". PubMed PMID: 19797868
  7. Background on the class of problem — herb- and supplement-induced liver injury generally, which is a leading cause of otherwise unexplained abnormal liver tests. PubMed topic search.

Evidence tier: case reports (the strongest tier available for rare idiosyncratic injury) in which the liver injury improved after the juice was stopped, set against negative animal toxicology. Anthraquinones are the leading candidate mechanism.

Key Research: Potassium, Kidneys and Hyperkalaemia

Less discussed than the liver signal, easier to predict, and in some ways more immediately dangerous, because severe hyperkalaemia is one of the few electrolyte problems that can kill within hours.

  1. Mueller, Scott, Sowinski and Prag, American Journal of Kidney Diseases, 2000 — "Noni juice (Morinda citrifolia): hidden potential for hyperkalemia?" measured potassium in noni juice samples at 56.3 mEq/L, similar to orange juice and tomato juice, and described a man with chronic renal insufficiency (long-term kidney disease) who drank noni juice and developed hyperkalaemia despite following a low-potassium diet. PubMed PMID: 10676732
  2. Dietary potassium in chronic kidney disease — the clinical context for why a "health juice" is a problem in chronic kidney disease. PubMed topic search.
  3. Drug-induced hyperkalaemia — ACE inhibitors, ARBs, potassium-sparing diuretics, trimethoprim and non-steroidal anti-inflammatory drugs all raise serum potassium, and noni adds to that load. PubMed topic search.
  4. Herbal products as an unrecognised potassium source — a recurring theme in nephrology case literature. PubMed topic search.

Evidence tier: measured composition plus a published case report. This is the most actionable warning on the whole topic. See Potassium Toxicity for what high potassium does.

Key Research: Pain, Joints and Inflammation

  1. Younos and colleagues, Planta Medica, 1990 — the classic report of analgesic and behavioural effects of a Morinda citrifolia extract in mice, and the origin of the modern pain claim. Animal. PubMed PMID: 1981810
  2. Basar and colleagues, Phytotherapy Research, 2010 — analgesic and anti-inflammatory activity of noni fruit preparations in rodent models, with attention to the fruit's constituent profile. Animal. PubMed PMID: 19548275
  3. Iridoid anti-inflammatory activity — deacetylasperulosidic acid and asperulosidic acid are noni's chemical signature and the compounds most plausibly behind any real anti-inflammatory effect. Mostly in vitro and animal. PubMed topic search.
  4. Human joint-pain and arthritis reports — small and short. PubMed topic search.

Evidence tier: preliminary. Reasonably consistent animal analgesia; human data too small to show a benefit. Full discussion in Pain and Joint Comfort.

Key Research: Immune Activity and Antioxidant Chemistry

  1. Hirazumi and Furusawa, Phytotherapy Research, 1999 — an immunomodulatory polysaccharide-rich substance from noni fruit juice with antitumour activity in mice. The foundation of the immune claim, and it is a mouse study. Animal. PubMed PMID: 10441776
  2. Hiramatsu and colleagues, Cancer Letters, 1993 — induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. This single cell-culture paper is where most of the "noni fights cancer" marketing ultimately comes from. In vitro, isolated compound. PubMed PMID: 7693328
  3. Wang and colleagues, Chemistry Central Journal, 2009 — "Antioxidant activity of noni juice in heavy smokers": a 30-day placebo-controlled trial in 285 heavy smokers (placebo, 29.5 mL or 118 mL of noni juice a day). Plasma superoxide anion radicals and lipid hydroperoxides fell in both noni groups and not in the placebo group. Human, short, surrogate endpoints. PubMed PMID: 19807926
  4. Wang and colleagues, Nutrition and Cancer, 2009 — "Morinda citrifolia (noni) reduces cancer risk in current smokers by decreasing aromatic DNA adducts": of 283 smokers enrolled, 203 completed the 1-month trial, and aromatic DNA adducts in blood cells fell by 44.9% after 1 to 4 oz of noni juice a day. The title's "reduces cancer risk" rests on this blood marker, not on cancer cases. Human, short, surrogate endpoint. PubMed PMID: 19838937
  5. Wang and colleagues, The Scientific World Journal, 2012 — noni juice and serum lipid profiles and other risk markers in 132 heavy smokers over one month. Human, small, short, surrogate endpoints. PubMed PMID: 23097636
  6. Wang and colleagues, Food Science & Nutrition, 2013 — reduction in lipid-peroxidation-derived DNA adducts in 245 heavy smokers over 1 month. Same caveats. PubMed PMID: 24804023
  7. Potterat and colleagues, Journal of Agricultural and Food Chemistry, 2007 — independent analytical work identifying markers and quantifying constituents across noni powders and commercial products, and the best demonstration of how much products differ from one another. PubMed PMID: 17696360
  8. Shin and colleagues, Nutrients, 2026 — "Fermented Noni Polysaccharides and Immune-Related Biomarkers in Adults with Recurrent URTIs: A Randomized, Double-Blind, Placebo-Controlled Trial". 100 adults aged 40 to under 75 who had had at least 2 upper respiratory tract infections (colds and similar infections) in the previous year took 975 mg a day of fermented noni polysaccharides or a placebo for 8 weeks. The number of infections at week 4, week 8 and overall did not differ significantly between the groups. Natural killer cell activity rose more in the noni group, but the difference was not statistically significant in the main analysis (p = 0.066, 0.087 and 0.145 at the three test ratios). The tablets were well tolerated, with no serious adverse events. Human, randomised, infection outcome. PubMed PMID: 42280334

Evidence tier: strong in vitro and animal signal, several small human surrogate-marker trials in smokers, and one 2026 trial that found no significant effect on the number of colds. Nothing here supports an immune or anticancer indication in people. Full discussion in Immune and Antioxidant.

Key Research: Energy, Quality of Life and Trial Design

  1. Issell and colleagues, Journal of Dietary Supplements, 2009 — a phase I dose-finding study in patients with advanced cancer that used quality-of-life instruments to help select a dose. It is the most methodologically transparent human noni study, and it was a dose-finding exercise, not a test of whether noni treats cancer. Preliminary human. PubMed PMID: 22435516
  2. Wang and colleagues, Acta Pharmacologica Sinica, 2002 — the most-cited noni review, and the reference behind a great deal of secondary writing. PubMed PMID: 12466051
  3. Placebo response in fatigue and wellbeing endpoints — essential context for why "I have more energy" testimonials cannot settle anything. PubMed topic search.
  4. Industry funding and outcome reporting in supplement trials — the methodological literature on why sponsorship matters. PubMed topic search.

Evidence tier: preliminary human at best. Full discussion in Energy and Quality of Life.

Traditional Use, Described Accurately

Noni is one of the canonical Polynesian "canoe plants" — species carried deliberately across the Pacific because they were too useful to leave behind — and its traditional profile deserves to be described accurately rather than repurposed as advertising.

What is not traditional: a sweetened daily juice drunk by healthy people as a general tonic. The ethnobotanical record describes a dye plant, a subsistence food, and targeted remedies — mostly leaf and root preparations for specific complaints. Daily wellness consumption is a 1990s commercial invention, and presenting it as ancient Polynesian practice misrepresents the tradition it borrows from. Evidence tier: traditional use only. Recorded as history, not offered as proof.

External Resources

Connections


Safety note and disclaimer. This page is health education, not medical advice. The liver case reports and the potassium data raise a concern for people with liver disease or a history of drug-induced liver injury, and for people with chronic kidney disease or on dialysis; there is no safety data for pregnancy or breastfeeding. Noni juice was measured at 56.3 mEq/L of potassium, similar to orange and tomato juice, and a man with long-term kidney disease developed hyperkalaemia (high blood potassium) while drinking it. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, potassium-sparing diuretics, trimethoprim and potassium supplements also raise potassium, so noni adds to their load; warfarin, methotrexate and other medicines that stress the liver add to the liver concern. One of the published liver cases ended in an urgent liver transplant. Jaundice (yellow skin or eyes), dark urine, pale stools, right-upper-abdominal pain, itching or unexplained fatigue and nausea are signs of liver injury that hospitals treat as urgent, and liver function tests are how it is measured. Noni is not a treatment for cancer, diabetes, kidney disease or inflammatory arthritis.

Back to Table of Contents